Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$37.12 - $46.52 $1 Million - $1.25 Million
26,959 New
26,959 $1.02 Million
Q3 2019

Nov 13, 2019

SELL
$59.06 - $72.15 $11,812 - $14,430
-200 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$43.37 - $59.54 $4,337 - $5,954
-100 Reduced 33.33%
200 $11,000
Q3 2018

Nov 13, 2018

BUY
$42.88 - $53.7 $12,864 - $16,110
300 New
300 $15,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.